NCT07029074

Brief Summary

In this study, it was aimed to investigate the acute effect of inspiratory muscle training of different intensities on intercostal muscle oxygenation in healthy individuals.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
1mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jul 2025Jun 2026

First Submitted

Initial submission to the registry

June 5, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 19, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

July 23, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2026

Expected
Last Updated

December 18, 2025

Status Verified

June 1, 2025

Enrollment Period

5 months

First QC Date

June 5, 2025

Last Update Submit

December 10, 2025

Conditions

Keywords

muscle oxygenationinspiratory muscle trainingintercostal muscle

Outcome Measures

Primary Outcomes (2)

  • Evaluation of intercostal muscle oxygenation

    Before the inspiratory muscle training sessions, the muscle oxygen saturation (SmO2) of the intercostal muscles in recovery during and after the training session will be measured using a Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA).

    Second, Third and Fourth day

  • Evaluation of intercostal muscle total hemoglobin level

    Before the inspiratory muscle training sessions, total hemoglobin level (THb) of the intercostal muscles in recovery during and after the training session will be measured using a Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA).

    Second, Third and Fourth day

Secondary Outcomes (8)

  • Evaluation of respiratory muscle strength

    First day

  • Evaluation of respiratory muscle endurance

    First day

  • Evaluation of pulmonary function (Forced expiratory volume in the first second (FEV1))

    First day

  • Evaluation pulmonary function (Forced vital capacity (FVC))

    First day

  • Evaluation of pulmonary function (FEV1/FVC)

    First day

  • +3 more secondary outcomes

Study Arms (3)

Sham inspiratory muscle training (Maximal inspiratory pressure (MIP) 0%)

EXPERIMENTAL

Individuals participating in the study will be randomly assigned sham inspiratory muscle training sessions maximal inspiratory pressure of 0% under the supervision of a specialist physiotherapist for 30 minutes.

Device: Sham inspiratory muscle training (MIP 0%)

MIP 30% inspiratory muscle training

EXPERIMENTAL

Individuals participating in the study will be randomly assigned inspiratory muscle training sessions maximal inspiratory pressure of 30% under the supervision of a specialist physiotherapist for 30 minutes.

Device: MIP 30% inspiratory muscle training

MIP 70% inspiratory muscle training

EXPERIMENTAL

Individuals participating in the study will be randomly assigned inspiratory muscle training sessions maximal inspiratory pressure of 70% under the supervision of a specialist physiotherapist for 30 minutes.

Other: MIP 70% inspiratory muscle training

Interventions

POWERbreathe Wellness (POWERbreathe International Ltd.., England, UK) device will be used for inspiratory muscle training.

Sham inspiratory muscle training (Maximal inspiratory pressure (MIP) 0%)

POWERbreathe Wellness (POWERbreathe International Ltd.., England, UK) device will be used for inspiratory muscle training.

MIP 30% inspiratory muscle training

POWERbreathe Wellness (POWERbreathe International Ltd.., England, UK) device will be used for inspiratory muscle training.

MIP 70% inspiratory muscle training

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Physically active (doing moderate intensity physical activity for at least 3 days a week for 150 minutes / week)
  • Volunteer to participate in the study

You may not qualify if:

  • Healthy individuals with any diagnosed chronic or systemic disease,
  • Smoke 10 packs x years or more,
  • Pneumonia or any acute infection,
  • Psychiatric disorder will excluded in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırşehir Ahi Evran University, Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit

Kırşehir, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Maximal Respiratory Pressures

Intervention Hierarchy (Ancestors)

Respiratory Function TestsDiagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Başak KAVALCI KOL, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This study was designed as a single-blind randomized, placebo-controlled, crossover study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 19, 2025

Study Start

July 23, 2025

Primary Completion

December 23, 2025

Study Completion (Estimated)

June 23, 2026

Last Updated

December 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Data will be stored in a locked cabinet.

Locations